From Medscape HIV/AIDS

Medscape Medical News from the:

19th Conference on Retroviruses and Opportunistic Infections (CROI)

March 05 - 08, 2012; Seattle, Washington

This coverage is not sanctioned by, nor a part of, the Conference on Retroviruses and Opportunistic Infections.

Conference News

CROI Central Obesity Tied to Neurologic Impairment in HIV
Medscape Medical News, March 16, 2012
CROI In Rural South Africa, ART Reduces HIV Incidence Rate
Medscape Medical News, March 15, 2012
CROI Prometheus Index Predicts Hepatitis C Treatment Response
Medscape Medical News, March 14, 2012
CROI Quad Regimen Safe, Effective for HIV
Medscape Medical News, March 13, 2012
CROI Uncontrolled HIV Linked to Decline in Lung Function
Medscape Medical News, March 12, 2012
CROI ART Interruption Safe for HIV-Positive Infants
Medscape Medical News, March 9, 2012
CROI Telaprevir Effective in HIV/HCV Coinfected Patients
Medscape Medical News, March 8, 2012
CROI More Patients Relapse in Gilead Hepatitis C Trial
Reuters Health Information, March 7, 2012
CROI Hormonal Birth Control Safe for HIV-Positive Women
Medscape Medical News, March 7, 2012
CROI Preexposure HIV Prophylaxis Effective Among Couples
Medscape Medical News, March 7, 2012

Medscape HIV/AIDS© WebMD, LLC

Expert Commentaries

News From CROI: Treatment of HIV/HCV Coinfection
Paul E. Sax, MD

New Drugs for HIV: Reports From CROI 2012
Paul E. Sax, MD

Previous CROI Coverage

18th Conference on Retroviruses and Opportunistic Infections

17th Conference on Retroviruses and Opportunistic Infections

16th Conference on Retroviruses and Opportunistic Infections